STABILISE Study:
Stroke: an evaluation of thrombectomy in the ageing brain version 1
SOFIA™ Aspiration Catheter
STABILISE study demonstrates that "Study indicated feasibility of a phase II RCT trial approach for assessing new thrombectomy devices. In a broad LAO stroke population ERIC and SOFIA were not statistically different from control devices. Larger trials are needed."
- Patients
66
- Country
UK
- Clinical Centers
4
- Design
RCT (45 ERIC/SOFIA vs 21 control)
- Scope
Patients ≥ 18 y.o. with LVO stroke treatable within 5.5hrs (8.5hrs for posterior circulation), of symptom onset, NIHSS≥ 6, treatable by ERIC/SOFIA or other standard CE approved mechanical thrombectomy devices.
- Purpose
Assessment of trial feasibility and technical efficacy and safety of use of ERIC and/or SOFIA to treat large vessel occlusion.
Endpoints
Primary: mTICI ≥2b-3 (Corelab assessed)
Secondary: mRS at 90 days and 365 days (independence and shift), mortality at 30 days, sICH, procedural complications
Efficacy results
mTICI 2b-3: 72% ERIC/SOFIA vs 86% Control
Safety results
Procedural complications: 9% ERIC/SOFIA vs 14% Control
Symptomatic ICH: 0% ERIC/SOFIA vs 5% Control
30-day mortality: 9% ERIC/SOFIA vs 14% Control
mRS 0-2 at 90 days: 40% ERIC/SOFIA vs 43% Control
mRS 0-2 at 365 days: 66% ERIC/SOFIA vs 62% Control
LINK TO STUDY PAGE ISRCTN Number: ISRCTN15698516
SPONSOR: Newcastle Clinical Trials Unit (UK)
Please refer to Instruction for Use (IFU) in the specific market/country that you are looking into:
MM1945 WW 04/26
Explore more studies
PHIL dAVF Study: Evaluation in the Endovascular Treatment of Intracranial Dural AVF
PHIL™ Liquid Embolic System
SESAME Study: Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic Stroke
SOFIA™ Aspiration Catheter
Request more information
The information you provide through this form is necessary to respond to your request and may be shared with the relevant Terumo Neuro group entity or entities responsible for handling it. For more information on how we process your personal data and on your rights, please refer to our privacy notice.